Search Results - "Fardon, T"

Multidimensional severity assessment in bronchiectasis: an analysis of seven European cohorts by McDonnell, M J, Aliberti, S, Goeminne, P C, Dimakou, K, Zucchetti, S C, Davidson, J, Ward, C, Laffey, J G, Finch, S, Pesci, A, Dupont, L J, Fardon, T C, Skrbic, D, Obradovic, D, Cowman, S, Loebinger, M R, Rutherford, R M, De Soyza, A, Chalmers, J D

“…Bronchiectasis is a multidimensional disease associated with substantial morbidity and mortality. Two disease-specific clinical prediction tools have been…”
Get more information

Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis by Barnes, M. L., Ward, J. H., Fardon, T. C., Lipworth, B. J.

“…Summary Background Addition of H1 antagonists to intranasal corticosteroid treatment of allergic rhinitis (AR) is common in clinical practice and recommended…”
Get full text

Supervised step-down of inhaled corticosteroids in the community – An observational study by Clearie, K.L, Jackson, C.M, Fardon, T.C, Williamson, P.A, Vaidyanathan, S, Burns, P, Lipworth, B.J

“…Summary Introduction Current asthma guidelines recommend step-down of inhaled corticosteroids (ICS) to the minimum dose required for control of symptoms. Aim…”
Get full text

Combined mediator blockade or topical steroid for treating the unified allergic airway by Barnes, M. L., Menzies, D., Fardon, T. C., Burns, P., Wilson, A. M., Lipworth, B. J.

“…Background:  Asthma and allergic rhinitis are manifestations of a single unified allergic airway, for which the best treatment is uncertain. Objective:  To…”
Get full text

Effects of intranasal corticosteroid on nasal adenosine monophosphate challenge in persistent allergic rhinitis by Barnes, M. L., Biallosterski, B. T., Fujihara, S., Gray, R. D., Fardon, T. C., Lipworth, B. J.

“…Background:  Response to a single dose nasal adenosine monophosphate challenge has been used as a surrogate inflammatory marker for allergic rhinitis…”
Get full text

Comparison of measured exhaled nitric oxide at varying flow rates by Menzies, D, Fardon, T, Burns, P, Lipworth, B J

Get full text

A51 BRONCHIECTASIS: CLINICAL AND EPIDEMIOLOGIC STUDIES: The Bronchiectasis Severity Index As A Surrogate Marker Of Morbidity, Quality Of Life And Future Risk by Finch, S M, Crichton, M, Fardon, T, Chalmers, J D

Get full text

A40 CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS BRONCHIECTASIS: A Quantitative And Qualitative Study To Understand Symptom Burden In Patients With Bronchiectasis by Dudgeon, E, Crichton, M, Scott, G, Finch, S, Fardon, T C, Chalmers, J D

“…Methods For the quantitative study, data from 70 BE patients completing the St Georges Respiratory Questionnaire (SGRQ), Leicester cough questionnaire (LCQ)…”
Get full text

Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma by Lee, Daniel K C, Fardon, Thomas C, Bates, Caroline E, Haggart, Kay, McFarlane, Lesley C, Lipworth, Brian J

“…There are no data comparing the relative effects of high-dose ciclesonide (CIC) and fluticasone propionate (FP) on airway and systemic outcomes in patients…”
Get more information

B16 CYSTIC FIBROSIS (CF) AND NON-CF BRONCHIECTASIS: Identifying Modifiable Risk Factors For Rapid Lung Function Decline In Bronchiectasis by Fardon, T, Finch, S M, Crichton, M, Dicker, A J, Marshall, S, Chalmers, J D

Get full text

D94 ADVANCES IN CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS BRONCHIECTASIS: Neutrophil Extracellular Traps Are Associated With Disease Severity In Bronchiectasis by Pumphrey, E, Keir, H, Fong, C, Finch, S, Fardon, T C, Dicker, A J, Chalmers, J D

“…Clinical assessments included lung function, exacerbation frequency, Quality of life (St. Georges Respiratory Questionnaire- SGRQ), hospital admissions and…”
Get full text

A31 MECHANISMS IN CYSTIC FIBROSIS AND OTHER BRONCHIECTATIC DISEASES: Validating New Methods Of Quantifying Neutrophil Extracellular Traps In Sputum And Bronchoalveolar Lavage From Patients With COPD And Bronchiectasis by Pumphrey, E, Keir, H, Fong, C, Sibila, O, Suarez-Cuartin, G, Finch, S, Fardon, T C, Dicker, A J, Chalmers, J D

“…Results: Sputum samples from 171 COPD patients and 257 bronchiectasis patients contained high concentrations of cell free DNA, variable levels of NE activity…”
Get full text

A multidisciplinary intervention to reduce antibiotic duration in lower respiratory tract infections by Murray, Colin, Shaw, Arlene, Lloyd, Matthew, Smith, Robin P, Fardon, Thomas C, Schembri, Stuart, Chalmers, James D

“…Prolonged antibiotic courses are common in patients with lower respiratory tract infections (LRTIs) and contribute to antibiotic resistance and side effects…”
Get full text

Effects of hydrofluoroalkane formulations of ciclesonide 320$mu;g once daily versus fluticasone propionate 220$mu;g twice daily on methacholine hyperresponsiveness in mild-to-moderate persistent asthma1 by FARDON, T

Get full text

B16 CYSTIC FIBROSIS (CF) AND NON-CF BRONCHIECTASIS: Anti-Pseudomonas AerugINOSa Igg Antibodies And Chronic Airway Infection In Non-Cystic Fibrosis Bronchiectasis by Suarez-Cuartin, G, Sibila, O, Smith, A, Abo-Leyah, H, Rodrigo-Troyano, A, Vidal, S, Plaza, V, Fardon, T C, Chalmers, J D

Get full text

D94 ADVANCES IN CYSTIC FIBROSIS AND NON-CYSTIC FIBROSIS BRONCHIECTASIS: Characterisation Of The Frequent Exacerbator Phenotype In Bronchiectasis: Data From The Friends Cohort by Chalmers, J D, Filonenko, A, Shteinberg, M, Goeminne, P C, McDonnell, M, Aliberti, S, Fardon, T C, Obradovic, D, Operschall, E, Gerlinger, C, Sotgiu, G, Dimakou, K, Polverino, E, De Soyza, A, Hill, A T

“…Disease severity was assessed with the Bronchiectasis Severity Index (BSI) and quality of life (QoL) with the St. Georges Respiratory Questionnaire (SGRQ)…”
Get full text

B16 CYSTIC FIBROSIS (CF) AND NON-CF BRONCHIECTASIS: Altered Lung Microbiota Profiles Are Associated With Disease Severity, Exacerbation Frequency And Neutrophilic Inflammation In Bronchiectasis by Dicker, A J, Fong, C, Crichton, M, Cassidy, A, Suarez-Cuartin, G, Sibila, O, Einarsson, G G, Ibrahim, W, Elborn, J, Palmer, C N A, Fardon, T, Marshall, S, Chalmers, J D

Get full text

Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic by Chalmers, James D., Al-Khairalla, Mudher, Short, Philip M., Fardon, Tom C., Winter, John H.

“…Clostridium difficile infection (CDI) remains a major healthcare problem associated with antibiotic use in hospitals. Recent years have seen a dramatic…”
Get full text

A47 CLINICAL ASPECTS AND DIAGNOSIS OF RESPIRATORY TRACT INFECTIONS: Role Of Secreted Mucins On Airway Bacterial Colonization In Non-Cystic Fibrosis Bronchiectasis by Suarez-Cuartin, G, Rodrigo-Troyano, A, Fardon, T C, Finch, S, Mateus, E, Garcia-Bellmunt, L, Sanchez-Reus, F, Vidal, S, Restrepo, M I, Chalmers, J D, Sibila, O

Get full text

Original article: Combined mediator blockade or topical steroid for treating the unified allergic airway by Barnes, M L, Menzies, D, Fardon, T C, Burns, P, Wilson, A M, Lipworth, B J

“…Asthma and allergic rhinitis are manifestations of a single unified allergic airway, for which the best treatment is uncertain. To compare the…”
Get full text